Zidovudine + Lamivudine Tablets

Zidovudine 300mg, Lamivudine 200mg Tablets Exporters

* To be consumed as directed by physician.

Zidovudine 300mg, Lamivudine 200mg Tablets

Zidovudine (300mg) + Lamivudine (150mg) + Nevirapine (200mg)
  • Zidovudine (300mg) + Lamivudine (150mg) + Nevirapine (200mg) tablet belongs to nucleoside reverse transcriptase inhibitors (NRTIs). The tablet is film coated, white to off-white colored, edged bevelled, capsule shaped, biconvex tablet debossed with ‘I’ on one side and ‘47’ on other side of the tablet.
  • The dose of this combination is fixed and cannot be changed once it is prescribed.
  • The tablet is given alone as complete regimen or in combination with other antiretrovirals medicine for treatment.
  • Zidovudine: It is a yellowish powder and nucleoside analog reverse transcriptase inhibitor (NRTI) and inhibits the enzyme reverse transcriptase. HIV uses this enzyme to make DNA and increase the inspection.
  • Zidovudine decreases the replication of the virus.
  • Lamivudine: It is a synthetic nucleoside and a (-) enantiomer of a dideoxy analog of cytidine. It is white to off- white crystalline solid and it is phosphorylated intracellularly to its active 5-triphosphate metabolite. It blocks the reverse transcriptase that HIV needs to make DNA and decreases the replication of the virus.
  • Nevirapine: It is a benzodiazepine non-nucleoside reverse transcriptase inhibitor. It reduces the viral loads of HIV and increases the counts of CD4 which strengthens the immune system and reduces the risk of AIDS.
  • The trio combination is used to treat HIV 1 infection in adults and children who weigh under 35kgs.
  • It is taken orally once and can be taken with or without food.
  • It strengthens the immune system by reducing the amount of HIV in the blood and reduces the risk of AIDS.
  • It prevents the multiplication of virus in the body and stand as a barrier for new infections, and viruses.
  • Observe for side effects of the tablet and consult your doctor immediately for treatment to avoid worsening of the complications.
  • Do not discontinue the dose unless your doctor suggests you to stop the medicine.
  • Monitor immediately if the patients show up the symptoms of hepatitis or hypersensitivity reaction.
(4.5 Rating)

Product Enquiry

Send Message